Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      AstraZeneca leukemia drug Calquence gets USFDA okay

      AstraZeneca leukemia drug Calquence gets USFDA okay

      Medical Dialogues Bureau24 Nov 2019 10:00 AM IST
      New Delhi: AstraZeneca said late on Thursday that the U.S. Food and Drug Administration (FDA) had given its go-ahead for the company's Calquence drug...
      CNS Pharma acquires worldwide rights for brain cancer drug Berubicin from Houston Pharma

      CNS Pharma acquires worldwide rights for brain cancer drug Berubicin from Houston Pharma

      Medical Dialogues Bureau24 Nov 2019 9:20 AM IST
      CNS Pharma intends to apply for orphan drug status for Berubicin with the FDA for the treatment of malignant glioma.New Delhi: CNS Pharmaceuticals, a...
      GE Healthcare gets USFDA clearance for deep learning-based CT image reconstruction technology

      GE Healthcare gets USFDA clearance for deep learning-based CT image reconstruction technology

      Medical Dialogues Bureau24 Nov 2019 9:17 AM IST
      New Delhi: GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration of its Deep Learning Image Reconstruction engine on...
      Bristol Myers Opdivo-Yervoy combo misses main goal in late-stage skin cancer trial

      Bristol Myers Opdivo-Yervoy combo misses main goal in late-stage skin cancer trial

      Medical Dialogues Bureau24 Nov 2019 9:15 AM IST
      The trial was testing Bristol-Myers' drugs Opdivo and Yervoy, against Opdivo alone, in patients with advanced melanoma.New Delhi: Bristol-Myers Squibb...
      Pharma Research being promoted by ICMR, others; Minister apprises parliament of initiatives

      Pharma Research being promoted by ICMR, others; Minister apprises parliament of initiatives

      Medical Dialogues Bureau23 Nov 2019 3:11 PM IST
      Minister of Health and Family Welfare, Ashwini Kumar Choubey while responding to the same stated that research in the field of pharmaceutical science,...
      Lupin unveils generic version of Sun Pharma Westcort Cream to treat skin conditions

      Lupin unveils generic version of Sun Pharma Westcort Cream to treat skin conditions

      Medical Dialogues Bureau23 Nov 2019 1:14 PM IST
      Hydrocortisone Valerate Cream USP, 0.2%, is the generic equivalent of the Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc., Lupin said.New...
      Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia

      Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia

      Medical Dialogues Bureau23 Nov 2019 9:18 AM IST
      Australia's Federal Court found that Johnson and Johnson (JnJ) subsidiary Ethicon had sold the devices (pelvic mesh implants) without warning women...
      Bayer, WHO collaborate to combat taeniasis, neurocystercosis

      Bayer, WHO collaborate to combat taeniasis, neurocystercosis

      Medical Dialogues Bureau23 Nov 2019 9:17 AM IST
      With praziquantel (“Biltricide”) and niclosamide (“Yomesan”) Bayer will provide two effective treatments, which are part of the latest WHO Model List...
      Achillion Pharma PNH treatment Danicopan gets European Medicines Agency PRIME Designation

      Achillion Pharma PNH treatment Danicopan gets European Medicines Agency PRIME Designation

      Medical Dialogues Bureau23 Nov 2019 9:00 AM IST
      New Delhi: Achillion Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families...
      Chinese strategy: Dr Reddys outsources part manufacturing to local parties

      Chinese strategy: Dr Reddy's outsources part manufacturing to local parties

      Medical Dialogues Bureau22 Nov 2019 12:50 PM IST
      Hyderabad: Betting big on the Chinese market, Dr Reddy's Laboratories which has plans to launch over 70 products in the East Asian country has started...
      Cabinet nod to extension of pharmaceuticals purchase policy for pharma PSUs

      Cabinet nod to extension of pharmaceuticals purchase policy for pharma PSUs

      Medical Dialogues Bureau22 Nov 2019 12:28 PM IST
      New Delhi: The Union Cabinet on Wednesday approved the extension of Pharmaceuticals Purchase Policy (PPP) for pharmaceutical Central Public Sector...
      FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer

      FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer

      Medical Dialogues Bureau22 Nov 2019 12:25 PM IST
      "Atezolizumab is the first cancer immunotherapy to receive approval from DCGI in India for the first-line treatment of extensive-stage small-cell lung...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok